Global Dolutegravir Tenders and GPN from across the Globe

Supply of Dolutegravir 50 Mg Tablets, Dolutegravir/Abacavir/Lamivudine 50mg + 600mg + 300mg Coated

Supply of Docusate Sodium/Sorbitol 120 Ml (2 Mg/Ml + 300 Mg/Ml) Clisma, Dolutegravir 10 Mg Tablets

Transposition of “Drugs 2022 - fifth tranche”: DOLUTEGRAVIR/RILPIVIRINE TABLET&#rl;&#nl;&#rl;&#nl;

Open House Drug Discount Agreements Dolutegravir and Rilpivirine, Atc J05ar21

Open House Original Discount Agreements 2023-29 - Dolutegravir/Lamivudine (Combination of Active

Open House Original Discount Agreements 2023-32 - Dolutegravir/Rilpivirine (Combination of Active

Supply of Dolutegravir/Rilpivirine 50mg + 25mg Coated Tablets, Domperido 10 Mg Tablets, Domperido

and Dolutegravir, Atc Code: J05ar25 for the Period from September 1St, 2023 to August 31St, 2025

Paragraph 1 Sgb V for Drugs with the Active Ingredients Dolutegravir and Rilpivirine (J05ar21) as Part

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Various Active Ingredients/S/Combinations with the Possibility of Conclusion at any Time as Part of the So-Called Open House Procedure